BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32754493)

  • 1. Hematological malignancies in relation with ABO blood group at a teaching hospital, Varanasi, India.
    Kumar S; Mahto N; Bharti A; Meena LP
    J Family Med Prim Care; 2020 May; 9(5):2309-2312. PubMed ID: 32754493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-Hematological Profile of Acute Leukemia Cases in Bihar: A Multiparameter Study in a Tertiary-Care Hospital.
    Shuchismita S; Jamal I; Raman RB; Choudhary V
    J Lab Physicians; 2023 Mar; 15(1):84-89. PubMed ID: 37064973
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
    Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
    Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
    Dewan E; Biswas D; Kakati B; Verma SK; Kotwal A; Oberoi A
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):99-105. PubMed ID: 26173033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
    Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
    Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic groundwater contamination and its health effects in the state of Uttar Pradesh (UP) in upper and middle Ganga plain, India: a severe danger.
    Ahamed S; Kumar Sengupta M; Mukherjee A; Amir Hossain M; Das B; Nayak B; Pal A; Chandra Mukherjee S; Pati S; Nath Dutta R; Chatterjee G; Mukherjee A; Srivastava R; Chakraborti D
    Sci Total Environ; 2006 Nov; 370(2-3):310-22. PubMed ID: 16899281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
    Weldetsadik AT
    Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article.
    Elzein HO
    Cureus; 2024 Mar; 16(3):e56812. PubMed ID: 38654809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varietal dataset of nutritionally important
    Singh A; Abhilash PC
    Data Brief; 2019 Jun; 24():103935. PubMed ID: 31061866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
    Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
    Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Manifestations in Leukemias and Their Correlation with Hematologic Parameters at a Tertiary Care Setting in South India.
    Soman S; Kasturi N; Srinivasan R; Vinod KV
    Ophthalmol Retina; 2018 Jan; 2(1):17-23. PubMed ID: 31047297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic manifestations in hematological malignancies: An observational study from a tertiary care health center in Eastern India.
    Thareja J; Minj A; Samal P; Panigrahi PK
    Indian J Ophthalmol; 2024 May; 72(5):659-663. PubMed ID: 38189493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
    Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
    Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome].
    Shao M; Tang P; Lyu XP; Yang QK; Zhu WT; Jin HF; Wang L; Zhao XQ; Liu X; Sun L
    Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):816-823. PubMed ID: 30392237
    [No Abstract]   [Full Text] [Related]  

  • 18. Spectrum of hematological malignancies and peripheral cytopenias.
    Jha A
    J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
    Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
    BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia.
    Ebrahim H; Fisha T; Debash H; Bisetegn H
    J Blood Med; 2022; 13():51-60. PubMed ID: 35210892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.